Because our previous results demonstrate decreased oncogene signaling via attenuation of HIF-1α and AR (also c-Myc) transcriptional activity we investigated known associated onco-miRs downstream of these transcription factors that may indicate potential mechanisms of panobinostat/everolimus combination anti-tumor activity. Here, HIF1A is linked to neoplasm.